Since 2013, diagnoses of multiple sclerosis (MS) in Finland take less time after symptom onset and treatments follow the ...

Tiziana and Renaissance will partner to accelerate clinical development and potential commercial launch of nasal foralumab.

B-cells were collected from people with and without MS, and those from patients had heightened antibody responses, ...

Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded ...

Tired of MS fatigue controlling your life? In the premiere episode of “Get Tough on Multiple Sclerosis,” Dr. Susan Payrovi ...

The study estimated annual mortality rates for 5,797 individuals with MS compared with 28,807 controls with a similar age, ...

Interactions between the body's immune system and bacteria that live in the gut become disrupted in multiple sclerosis (MS), ...

Switching from CD20 inhibitors to fumarate therapies reduces healthcare visits and infection-related costs, while controlling ...

Columnist Desiree Lama describes her journey with MS-related bladder problems that were brought under control but are now ...

Findings from the implanted scaffold led researchers to block specific inflammatory molecules, easing disease severity in a ...

Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...

Stress management strategies such as mindfulness and exercise can help you manage your multiple sclerosis (MS) diagnosis.